Mumbai: Global pharma major Lupin Limited has announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) ...

Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...

The product is bioequivalent to Novo Nordisk Inc's Victoza injection. It is indicated as an adjunct to diet and exercise to ...

Global pharma major Lupin Limited (Lupin) announced the launch of liraglutide injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen, in the United States. Liraglutide injection, 18 mg/3 mL ...

Lupin has announced the launch of its Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen in the United States.

Lupin has received approval from the Food and Drug Administration for liraglutide injection single-patient-use prefilled pens and glucagon for injection vials. Both of these products will be ...

Ozempic shortages expected throughout 2024 Victoza shortages expected until at least Q2 2024 Diabetes drug Ozempic used 'off label' to treat obesity Nov 21 (Reuters) - Novo Nordisk (NOVOb.CO), opens ...